Patent intelligence · AU
AU 2005207635
Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds
Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds
Patent details — AU 2005207635
- Jurisdiction
- AU
- Status
- expired
- Grant date
- Aug 4, 2005
- Expiration
- Jul 30, 2025
- Applicant
- BIOMAS LTD [IT]
- CPC classes
- A61K 33/ 04 A I, A61K/31095, A61K/31555, A61K/3304
Quick answer
AU 2005207635 (Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds) is held by BIOMAS LTD [IT]. Status: expired. Granted Aug 4, 2005. Expires Jul 30, 2025 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BIOMAS LTD [IT]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 33/ 04 A I, A61K/31095, A61K/31555, A61K/3304, A61K/4506, A61K/4706
More from BIOMAS LTD [IT]
Related pharmaceutical patents in our USPTO index.
-
WO 2026087531
FORMULATIONS DE CLASCOTÉRONE ET LEURS MÉTHODES D'UTILISATION
granted -
WO 2026057588
POLYTHÉRAPIE À BASE DE CLASCOTÉRONE ET DE MINOXIDIL POUR LE TRAITEMENT DE LA PERTE DES CHEVEUX
granted -
WO 2025172818
POLYTHÉRAPIE À BASE DE PYRILUTAMIDE
granted -
WO 2025125508
COMBINAISONS DE CORTEXOLONE-17ΑLPHA-PROPIONATE POUR LE TRAITEMENT DE L'ACNÉ
granted -
AR 132316
TRATAMIENTO COMBINADO CON CLASCOTERONA Y MINOXIDIL
granted -
WO 2025068281
CORTÉXOLONE-17α-PROPIONATE POUR LE TRAITEMENT D'ÉRUPTIONS ACNÉIFORMES
granted -
EP 4529925
CORTEXOLON-17-ALPHA-PROPIONAT ZUR BEHANDLUNG VON AKNEIFORMEN ERUPTEN
granted -
US 2018169113
HIGH CONCENTRATION FORMULATION
granted
Frequently asked questions
What is US patent 2005207635?
AU 2005207635 (Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds) is held by BIOMAS LTD [IT]. Status: expired. Granted Aug 4, 2005. Expires Jul 30, 2025 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns AU 2005207635?
BIOMAS LTD [IT] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 12 pharmaceutical patents for this assignee.
When does AU 2005207635 expire?
Our index shows an expiration date of Jul 30, 2025 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.